DK2451284T3 - Nye guldbaserede nanokrystaller til medicinske behandlinger og elektrokemiske processer til fremstilling deraf - Google Patents
Nye guldbaserede nanokrystaller til medicinske behandlinger og elektrokemiske processer til fremstilling deraf Download PDFInfo
- Publication number
- DK2451284T3 DK2451284T3 DK10797874.4T DK10797874T DK2451284T3 DK 2451284 T3 DK2451284 T3 DK 2451284T3 DK 10797874 T DK10797874 T DK 10797874T DK 2451284 T3 DK2451284 T3 DK 2451284T3
- Authority
- DK
- Denmark
- Prior art keywords
- gold
- nanocrystals
- electrode
- liquid
- figures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
- A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0545—Dispersions or suspensions of nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0553—Complex form nanoparticles, e.g. prism, pyramid, octahedron
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B1/00—Single-crystal growth directly from the solid state
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/02—Elements
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/60—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape characterised by shape
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
- C30B7/12—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by electrolysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Claims (10)
- NYE GULDBASEREDE NANOKRYSTALLER TIL MEDICINSKE BEHANDLINGER OG ELEKTROKEMISKE PROCESSER TIL FREMSTILLING DERAF1. Farmaceutisk acceptabel suspensionssammensætning omfattende: a. ) vand; b. ) en forarbejdningsforstærker; og c. ) guldnanokrystaller suspenderet i vandet, så der dannes en suspension, hvori guldnanokrystallerne: 1. ) har overflader, der: (1) i det væsentlige er fri for organiske eller andre urenheder eller film; eller (2) ikke har kemiske bestanddele adhæreret eller hæftet på sig, der danner et lag, en overflade eller en film, som dækker mindst 50 % af krystallen og fortrinsvis mindst 25 % af krystallen; ii. ) har en modalpartikelstørrelse på mindre end 100 nm; iii. ) er til stede i suspensionen i en koncentration på 2-200 ppm; og iv. ) indeholder mindst ét rumligt udvidet lavt indekskrystalplan udvalgt fra gruppen bestående af {111}, {110} og {100} og deres ækvivalenter; og hvori suspensionen har en pH på mellem 4,0 til 9,5 og et zetapotentiale på mindst -20 mV.
- 2. Sammensætning ifølge krav 1, hvori suspensionen har en pH på mellem 5,0 til 9,5.
- 3. Sammensætning ifølge krav 1 eller 2, hvori suspensionen har et zetapotentiale på mindst -40 mV.
- 4. Sammensætning ifølge et hvilket som helst af kravene 1 til 3, hvori nanokrystallerne har en modalpartikelstørrelse på mindre end 5 0 nm.
- 5. Sammensætning ifølge et hvilket som helst af kravene 1 til 4, hvori forarbejdningsforstærkeren omfatter natriumbicarbonat.
- 6. Sammensætning ifølge et hvilket som helst af kravene 1 til 5, hvori nanokrystallerne er formet, hvilke former omfatter pentagonale bipyramider og tetraedre i et område på 15 til 50 %.
- 7. Sammensætning ifølge et hvilket som helst af kravene 1 til 6 til anvendelse i behandlingen af en patient med en tilstand, der er modtagelig over for guldterapi.
- 8. Sammensætning ifølge krav 7, hvori tilstanden er udvalgt fra gruppen bestående af reumatoid artritis, osteoartritis, systemisk lupus erythematosus, ulcerativ colitis, Crohns sygdom, multipel sklerose, psoriasis, eksem, uveitis, diabetes mellitus, glomerulonefritis, aterosklerotisk karsygdom og infarkt, astma, kronisk obstruktiv lungesygdom, HIV, HBV, HCV, tuberkulose, malaria, orm og cancer(e).
- 9. Sammensætning til anvendelse ifølge krav 7, hvori tilstanden er artritis eller multipel sklerose.
- 10. Sammensætning ifølge et hvilket som helst af kravene 1 til 6 til oral administration.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22394409P | 2009-07-08 | 2009-07-08 | |
US22615309P | 2009-07-16 | 2009-07-16 | |
US22825009P | 2009-07-24 | 2009-07-24 | |
US23557409P | 2009-08-20 | 2009-08-20 | |
US24980409P | 2009-10-08 | 2009-10-08 | |
US26364809P | 2009-11-23 | 2009-11-23 | |
US29469010P | 2010-01-13 | 2010-01-13 | |
PCT/US2010/041427 WO2011006007A1 (en) | 2009-07-08 | 2010-07-08 | Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2451284T3 true DK2451284T3 (da) | 2017-05-01 |
Family
ID=43429549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10797874.4T DK2451284T3 (da) | 2009-07-08 | 2010-07-08 | Nye guldbaserede nanokrystaller til medicinske behandlinger og elektrokemiske processer til fremstilling deraf |
Country Status (16)
Country | Link |
---|---|
US (5) | US9603870B2 (da) |
EP (1) | EP2451284B8 (da) |
JP (4) | JP6059015B2 (da) |
KR (3) | KR102051248B1 (da) |
CN (1) | CN102548417B (da) |
AU (1) | AU2010271298B2 (da) |
BR (1) | BR112012000311B1 (da) |
CA (1) | CA2767428C (da) |
DK (1) | DK2451284T3 (da) |
ES (1) | ES2623504T3 (da) |
IL (1) | IL217408A (da) |
MX (1) | MX350309B (da) |
PH (1) | PH12017501884A1 (da) |
RU (1) | RU2568850C2 (da) |
SG (4) | SG10202108051XA (da) |
WO (1) | WO2011006007A1 (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2178796T3 (da) * | 2007-07-11 | 2021-03-01 | Clene Nanomedicine Inc | Kontinuerlig fremgangsmåde til behandling af væsker og fremstilling af visse bestanddele |
US9387452B2 (en) | 2009-01-14 | 2016-07-12 | Gr Intellectual Reserve, Llc. | Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom |
AU2010204991B2 (en) | 2009-01-15 | 2016-01-14 | Clene Nanomedicine, Inc. | Continuous semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom |
DK2451284T3 (da) * | 2009-07-08 | 2017-05-01 | Clene Nanomedicine Inc | Nye guldbaserede nanokrystaller til medicinske behandlinger og elektrokemiske processer til fremstilling deraf |
WO2011158176A2 (en) * | 2010-06-17 | 2011-12-22 | University Of Kwazulu-Natal | Gold complexes |
US20130323166A1 (en) * | 2010-09-10 | 2013-12-05 | William Beaumont Hospital | Radiation Therapy for Treating Alzheimer's Disease |
KR102103534B1 (ko) * | 2011-03-30 | 2020-04-23 | 클레네 나노메디슨, 인크. | 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도 |
EP2735389A1 (de) * | 2012-11-23 | 2014-05-28 | Universität Duisburg-Essen | Verfahren zur Herstellung reiner, insbesondere kohlenstofffreier Nanopartikel |
HUE054255T2 (hu) | 2013-05-08 | 2021-08-30 | Clene Nanomedicine Inc | Eljárás és kezelés demielinizáción és diszmielinizáción alapuló betegségekhez és/vagy remielinizáció elõsegítésére |
GB2529185B (en) | 2014-08-12 | 2021-03-03 | Kathrein Se | Method and system for relaying telecommunications signals wtih efficient joint capacity |
EP3689234A1 (en) | 2014-10-30 | 2020-08-05 | Kardium Inc. | Systems and methods for ablating tissue |
KR102328995B1 (ko) * | 2014-11-26 | 2021-11-23 | 나노리소스 주식회사 | 폭발형 나노다이아몬드의 분리 방법 |
CN104867267B (zh) * | 2015-03-15 | 2017-10-27 | 李洪 | 节能减灾装置 |
CN104759753B (zh) * | 2015-03-30 | 2016-08-31 | 江苏大学 | 多系统自动化协调工作提高激光诱导空化强化的方法 |
CN107708749B (zh) * | 2015-05-07 | 2021-02-02 | 密歇根大学董事会 | 用于化学空气污染物的电流体动力增强的破坏和生物剂的空气中灭活的方法 |
JP6590309B2 (ja) * | 2015-07-31 | 2019-10-16 | 学校法人関東学院 | 導電層付プラスチック基板及びその製造方法 |
WO2017210060A2 (en) | 2016-05-25 | 2017-12-07 | University Of Florida Research Foundation, Inc. | Light-driven synthesis of plasmonic nanoparticles and nanomaterials |
US10729718B2 (en) * | 2016-08-05 | 2020-08-04 | Shenzhen Profound-View Pharma Tech Co., Ltd | Substances containing AuCs and preparation method and use thereof |
US10300551B2 (en) * | 2016-11-14 | 2019-05-28 | Matthew Fagan | Metal analyzing plasma CNC cutting machine and associated methods |
US10195683B2 (en) * | 2016-11-14 | 2019-02-05 | Matthew Fagan | Metal analyzing plasma CNC cutting machine and associated methods |
US10029019B1 (en) | 2017-01-20 | 2018-07-24 | Xueyun Gao | Method for mitigating osteoporosis using metallic gold cluster molecules |
CN108569483A (zh) * | 2017-03-13 | 2018-09-25 | 富泰华工业(深圳)有限公司 | 智能取液系统 |
CN107217279B (zh) * | 2017-05-31 | 2018-10-02 | 东北大学 | 一种电解法制备金属纳米颗粒的方法 |
CN107290422B (zh) * | 2017-07-20 | 2019-04-19 | 浙江大学 | 一种基于电化学增强反射光谱信号的生化检测系统及方法 |
TWI651095B (zh) * | 2017-10-18 | 2019-02-21 | 晶碩光學股份有限公司 | 具有抗敏舒緩效果的眼用產品 |
CN111886014A (zh) | 2017-12-19 | 2020-11-03 | 纳米生物技术公司 | 用于增强脑性能或治疗应激的纳米粒子 |
EP3727349A1 (en) | 2017-12-19 | 2020-10-28 | Nanobiotix | Nanoparticles for use for treating a neuronal disorder |
EP3696534A1 (en) * | 2019-02-14 | 2020-08-19 | SmartDyeLivery GmbH | Method for determining physicochemical properties of nanoscale systems (nss) |
CN110905454B (zh) * | 2019-11-29 | 2022-01-04 | 南通仁隆科研仪器有限公司 | 一种水合物储层井间电学动态监控模拟实验装置 |
RU2725197C1 (ru) * | 2020-02-12 | 2020-06-30 | федеральное государственное бюджетное образовательное учреждение высшего образования «Ижевская государственная медицинская академия» Министерства здравоохранения Российской Федерации | Метод оценки висцеральной гиперчувствительности |
KR102408166B1 (ko) * | 2020-04-02 | 2022-06-10 | 아주대학교산학협력단 | 세포 배양이 가능한 세포 유래물 분석용 센서칩, 및 이를 이용한 세포 활성도 정량 분석 방법 |
CN112571790A (zh) * | 2020-11-04 | 2021-03-30 | 即时智造科技(上海)有限公司 | 一种sls3d打印自动冷却装置 |
CN112683710B (zh) * | 2020-12-02 | 2024-04-16 | 大连理工大学 | 一种氯离子侵蚀下钢筋混凝土桥板加速腐蚀的试验装置 |
CN115351289B (zh) * | 2022-09-01 | 2023-12-29 | 杭州师范大学 | 一种利用三元表面活性剂制备微型金纳米棒的方法及其产品 |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR432101A (fr) | 1910-10-26 | 1911-11-29 | I S Petzholdt Maschinen Fabrik | Procédé et machine destinés au traitement du cacao fluide |
JPS529615B1 (da) | 1970-03-31 | 1977-03-17 | ||
JPS5747272B2 (da) | 1974-12-13 | 1982-10-08 | ||
DE2854946A1 (de) | 1978-12-20 | 1980-07-10 | Agfa Gevaert Ag | Fotografisches farbdiffusionsuebertragungsverfahren |
US6638413B1 (en) | 1989-10-10 | 2003-10-28 | Lectro Press, Inc. | Methods and apparatus for electrolysis of water |
CA2104355C (en) | 1993-08-18 | 1997-06-17 | Ion I. Inculet | Method and apparatus for ozone generation and treatment of water |
DE19522619C2 (de) | 1995-06-22 | 1998-11-12 | Fischer & Krecke Gmbh & Co | Verfahren zur Herstellung von Bodenbeuteln mit Innenriegel |
US5876663A (en) | 1995-11-14 | 1999-03-02 | The University Of Tennessee Research Corporation | Sterilization of liquids using plasma glow discharge |
ZA9610018B (en) | 1995-11-28 | 1997-05-28 | Austech Pty Ltd | Liquid sterilisation apparatus |
AUPO502297A0 (en) | 1997-02-10 | 1997-03-06 | Austech Pty Ltd | Liquid purification apparatus |
US5965994A (en) | 1997-06-20 | 1999-10-12 | Seo; Dong Il | Automatic vertical moving systems and control methods therefor |
US6558638B2 (en) | 1998-03-14 | 2003-05-06 | Splits Technologies Limited | Treatment of liquids |
US7527787B2 (en) * | 2005-10-19 | 2009-05-05 | Ibc Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
CA2272596A1 (en) | 1999-05-21 | 2000-11-21 | Lawrence A. Lambert | Waste water treatment method and apparatus |
US7135195B2 (en) | 1999-06-01 | 2006-11-14 | American Silver, Llc | Treatment of humans with colloidal silver composition |
US6214299B1 (en) | 1999-06-01 | 2001-04-10 | Robert J. Holladay | Apparatus and method for producing antimicrobial silver solution |
US7238472B2 (en) | 2001-05-25 | 2007-07-03 | Nanosphere, Inc. | Non-alloying core shell nanoparticles |
US6962679B2 (en) | 2001-07-11 | 2005-11-08 | Battelle Memorial Institute | Processes and apparatuses for treating halogen-containing gases |
US7135054B2 (en) | 2001-09-26 | 2006-11-14 | Northwestern University | Nanoprisms and method of making them |
TWI255695B (en) * | 2001-10-12 | 2006-06-01 | Phild Co Ltd | Method and device for producing ultrafine dispersion of noble metal |
TW561085B (en) | 2001-10-29 | 2003-11-11 | Phild Co Ltd | Method and device for producing metal powder |
US7972390B2 (en) | 2002-03-21 | 2011-07-05 | Gr Intellectual Reserve, Llc | Methods for controlling crystal growth, crystallization, structures and phases in materials and systems |
GB0208263D0 (en) | 2002-04-10 | 2002-05-22 | Dow Corning | Protective coating composition |
US7118852B2 (en) | 2002-04-11 | 2006-10-10 | Throwleigh Technologies, L.L.C. | Methods and apparatus for decontaminating fluids |
US6749759B2 (en) | 2002-07-12 | 2004-06-15 | Wisconsin Alumni Research Foundation | Method for disinfecting a dense fluid medium in a dense medium plasma reactor |
US20040022702A1 (en) | 2002-07-30 | 2004-02-05 | Christensen Herbert E. | Apparatus and method for automatically feeding the silver electrode into the solutiion |
JP2004124155A (ja) | 2002-10-01 | 2004-04-22 | Sumitomo Electric Ind Ltd | 微小金属粉末の製造方法および微小金属粉末の製造装置 |
US6802981B2 (en) | 2002-11-05 | 2004-10-12 | Aquapure Technologies Ltd. | Method for purification and disinfection of water |
EP1598072A4 (en) * | 2003-02-20 | 2006-04-19 | Shetech Co Ltd | THERAPEUTIC DRUG CONTAINING NOBLE METAL FINE PARTICLES |
CN1798858B (zh) | 2003-04-02 | 2010-06-16 | 西北大学 | 控制纳米颗粒生长的方法 |
US20060249705A1 (en) | 2003-04-08 | 2006-11-09 | Xingwu Wang | Novel composition |
JP2007500606A (ja) * | 2003-07-28 | 2007-01-18 | ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア | ラングミュア−ブロジェットナノ構造体単層 |
WO2005023406A2 (en) | 2003-09-10 | 2005-03-17 | Ramot At Tel-Aviv University Ltd. | Production of nanoparticles and microparticles |
US7276283B2 (en) | 2004-03-24 | 2007-10-02 | Wisconsin Alumni Research Foundation | Plasma-enhanced functionalization of carbon-containing substrates |
US7486705B2 (en) | 2004-03-31 | 2009-02-03 | Imra America, Inc. | Femtosecond laser processing system with process parameters, controls and feedback |
US20060068026A1 (en) * | 2004-08-11 | 2006-03-30 | Hu Michael Z | Thermal electrochemical synthesis method for production of stable colloids of "naked" metal nanocrystals |
JP4943851B2 (ja) | 2004-09-15 | 2012-05-30 | 国立大学法人京都大学 | 金属微粒子の製造方法 |
WO2006137851A2 (en) | 2004-09-16 | 2006-12-28 | Virginia Tech Intellectual Properties, Inc. | Preparation of stable high concentration colloidal metal particulate systems |
ES2392443T3 (es) * | 2004-10-05 | 2012-12-10 | Inovex Co., Ltd. | Uso de una solución acuosa que contiene coloide de platino para el tratamiento de síntomas psiquiátricos |
EP1825269A4 (en) * | 2004-12-13 | 2012-06-06 | Univ South Carolina | SURFACE-REINFORCED RAMAN SPECTROSCOPY USING SHAPED GOLDNANOPARTICLE |
MX2007008305A (es) | 2005-01-05 | 2008-03-11 | American Silver Llc | Composiciones a base de plata, geles de plata y plata/agua, y metodos para elaborar y utilizar las mismas. |
US7588624B2 (en) | 2005-03-10 | 2009-09-15 | Northwestern University | Method of producing gold nanoprisms |
CN100467118C (zh) | 2005-08-08 | 2009-03-11 | 鸿富锦精密工业(深圳)有限公司 | 纳米粒子制备装置 |
KR100726713B1 (ko) | 2005-08-26 | 2007-06-12 | 한국전기연구원 | 액중 전기폭발에 의한 나노분말 제조 방법 및 장치 |
WO2007044609A1 (en) | 2005-10-06 | 2007-04-19 | Pionetics Corporation | Electrochemical ion exchange treatment of fluids |
US7758846B2 (en) * | 2005-12-16 | 2010-07-20 | Battelle Memorial Institute | Methods of producing hydrogen via the water-gas shift reaction over a Pd-Zn catalyst |
US20070267289A1 (en) | 2006-04-06 | 2007-11-22 | Harry Jabs | Hydrogen production using plasma- based reformation |
US8088193B2 (en) | 2006-12-16 | 2012-01-03 | Taofang Zeng | Method for making nanoparticles |
US7862782B2 (en) | 2007-01-12 | 2011-01-04 | Wisconsin Alumni Research Foundation | Apparatus and methods for producing nanoparticles in a dense fluid medium |
DK2178796T3 (da) * | 2007-07-11 | 2021-03-01 | Clene Nanomedicine Inc | Kontinuerlig fremgangsmåde til behandling af væsker og fremstilling af visse bestanddele |
JP2009032756A (ja) * | 2007-07-25 | 2009-02-12 | Sony Corp | 半導体製造装置 |
CN101952197A (zh) | 2008-01-14 | 2011-01-19 | 曾桃芳 | 一种制造纳米颗粒或微细颗粒的方法 |
EP2123262A1 (en) * | 2008-05-20 | 2009-11-25 | Consorzio per il Centro di Biomedica Moleculare Scrl | Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier |
AU2010204991B2 (en) * | 2009-01-15 | 2016-01-14 | Clene Nanomedicine, Inc. | Continuous semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom |
US8246714B2 (en) | 2009-01-30 | 2012-08-21 | Imra America, Inc. | Production of metal and metal-alloy nanoparticles with high repetition rate ultrafast pulsed laser ablation in liquids |
DK2451284T3 (da) * | 2009-07-08 | 2017-05-01 | Clene Nanomedicine Inc | Nye guldbaserede nanokrystaller til medicinske behandlinger og elektrokemiske processer til fremstilling deraf |
EP2275137A1 (en) | 2009-07-10 | 2011-01-19 | Nanobiotix | Metallic nanoparticles, preparation and uses thereof |
US8858676B2 (en) | 2010-02-10 | 2014-10-14 | Imra America, Inc. | Nanoparticle production in liquid with multiple-pulse ultrafast laser ablation |
US8802234B2 (en) | 2011-01-03 | 2014-08-12 | Imra America, Inc. | Composite nanoparticles and methods for making the same |
-
2010
- 2010-07-08 DK DK10797874.4T patent/DK2451284T3/da active
- 2010-07-08 SG SG10202108051XA patent/SG10202108051XA/en unknown
- 2010-07-08 KR KR1020187036075A patent/KR102051248B1/ko active IP Right Grant
- 2010-07-08 SG SG2012001319A patent/SG177565A1/en unknown
- 2010-07-08 KR KR1020127003346A patent/KR101931381B1/ko active Application Filing
- 2010-07-08 RU RU2012104247/15A patent/RU2568850C2/ru active
- 2010-07-08 EP EP10797874.4A patent/EP2451284B8/en active Active
- 2010-07-08 WO PCT/US2010/041427 patent/WO2011006007A1/en active Application Filing
- 2010-07-08 US US13/382,781 patent/US9603870B2/en active Active
- 2010-07-08 KR KR1020197034776A patent/KR102131575B1/ko active IP Right Grant
- 2010-07-08 CN CN201080036729.4A patent/CN102548417B/zh active Active
- 2010-07-08 CA CA2767428A patent/CA2767428C/en active Active
- 2010-07-08 BR BR112012000311-9A patent/BR112012000311B1/pt active IP Right Grant
- 2010-07-08 MX MX2012000489A patent/MX350309B/es active IP Right Grant
- 2010-07-08 AU AU2010271298A patent/AU2010271298B2/en active Active
- 2010-07-08 ES ES10797874.4T patent/ES2623504T3/es active Active
- 2010-07-08 SG SG10201908339R patent/SG10201908339RA/en unknown
- 2010-07-08 JP JP2012519739A patent/JP6059015B2/ja active Active
- 2010-07-08 SG SG10201403497QA patent/SG10201403497QA/en unknown
-
2012
- 2012-01-05 IL IL217408A patent/IL217408A/en active IP Right Grant
-
2016
- 2016-08-18 JP JP2016160686A patent/JP6383763B2/ja active Active
-
2017
- 2017-03-21 US US15/465,092 patent/US10449217B2/en active Active
- 2017-10-18 PH PH12017501884A patent/PH12017501884A1/en unknown
-
2018
- 2018-08-06 JP JP2018147599A patent/JP6703052B2/ja active Active
-
2019
- 2019-08-08 US US16/535,672 patent/US10980832B2/en active Active
-
2020
- 2020-04-28 JP JP2020079822A patent/JP7014851B2/ja active Active
-
2021
- 2021-04-06 US US17/223,336 patent/US20210236542A1/en active Pending
- 2021-04-13 US US17/229,013 patent/US20210361699A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2451284T3 (da) | Nye guldbaserede nanokrystaller til medicinske behandlinger og elektrokemiske processer til fremstilling deraf | |
AU2022202803B2 (en) | Novel gold-based nanocrystals | |
RU2617055C2 (ru) | Новые суспензии основанных на золоте и платине биметаллических нанокристаллов, электрохимические способы их производства и их применения |